Some studies [14,15] describe a malignancy-related gradual reduction of RKIP levels in melanoma patients, but however, these were performed with a small cohort of patients; a larger study would be required in order to establish the real diagnostic or prognostic value of this marker in melanoma. The gene discussed is PEBP1; the disease is melanoma.